Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kirsten Björnlinger"'
Autor:
Björn Tavelin, Mihajl Seke, David Norman, Lars Franzén, Anders Widmark, Per Fransson, Lars Beckman, Björn Zackrisson, Morten Høyer, Per Nilsson, Camilla Thellenberg-Karlsson, Elisabeth Kjellén, Jon Kindblom, Adalsteinn Gunnlaugsson, Bengt Johansson, Kirsten Björnlinger, Claes Ginman, Magnus Lagerlund, Måns Agrup
Publikováno v:
Fransson, P, Nilsson, P, Gunnlaugsson, A, Beckman, L, Tavelin, B, Norman, D, Thellenberg-Karlsson, C, Hoyer, M, Lagerlund, M, Kindblom, J, Ginman, C, Johansson, B, Björnlinger, K, Seke, M, Agrup, M, Zackrisson, B, Kjellén, E, Franzén, L & Widmark, A 2021, ' Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 235-245 . https://doi.org/10.1016/S1470-2045(20)30581-7
Background: The HYPO-RT-PC trial compared conventionally fractionated radiotherapy with ultra-hypofractionated radiotherapy in patients with localised prostate cancer. Ultra-hypofractionation was non-inferior to conventional fractionation regarding 5
Autor:
Camilla Thellenberg-Karlsson, Lars Beckman, Adalsteinn Gunnlaugsson, Lars Franzén, Kirsten Björnlinger, Elisabeth Kjellén, Claes Ginman, Per Fransson, Harald Anderson, Magnus Lagerlund, Mihajl Seke, Björn Tavelin, Måns Agrup, Anders Widmark, Bengt Johansson, Morten Høyer, Jon Kindblom, David Norman, Per Nilsson, Björn Zackrisson
Publikováno v:
Widmark, A, Gunnlaugsson, A, Beckman, L, Thellenberg-Karlsson, C, Hoyer, M, Lagerlund, M, Kindblom, J, Ginman, C, Johansson, B, Björnlinger, K, Seke, M, Agrup, M, Fransson, P, Tavelin, B, Norman, D, Zackrisson, B, Anderson, H, Kjellén, E, Franzén, L & Nilsson, P 2019, ' Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer : 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial ', The Lancet, vol. 394, no. 10196, pp. 385-395 . https://doi.org/10.1016/S0140-6736(19)31131-6
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
Summary Background Hypofractionated radiotherapy for prostate cancer has gained increased attention due to its proposed high radiation-fraction sensitivity. Recent reports from studies comparing moderately hypofractionated and conventionally fraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f2576a4a1ca40683b1abdff06eb0d1
https://pure.au.dk/portal/da/publications/ultrahypofractionated-versus-conventionally-fractionated-radiotherapy-for-prostate-cancer(4232e2f3-4a07-4b9e-b725-107553d11dbd).html
https://pure.au.dk/portal/da/publications/ultrahypofractionated-versus-conventionally-fractionated-radiotherapy-for-prostate-cancer(4232e2f3-4a07-4b9e-b725-107553d11dbd).html
Autor:
Camilla Thellenberg-Karlsson, Morten Høyer, Anders Widmark, Per Fransson, Mihalj Seke, Elisabeth Kjellén, Jon Kindblom, Lars Franzén, Magnus Lagerlund, Bengt Johansson, Adalsteinn Gunnlaugsson, Per Nilsson, Kirsten Björnlinger, Claes Ginman, Lars Beckman
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:938-939
Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer : Early Toxicity Results from the Scandinavian Randomized Phase III Trial "HYPO-RT-PC"